A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Category | Primary Site | Code? |
|---|---|---|---|
| 131I-MIBG | Radiation | See Remarks | |
| 5-Aza-2'Deoxy-cytidine | Chemotherapy | CML | Yes |
| 5-FP | Chemotherapy | Breast, gastric, head & neck, liver cancer | Yes |
| ABT 888 | Chemotherapy | Ovary | Yes |
| ADXS-HPV | Biologic therapy (BRM, immunotherapy) | Cervix | See Remarks |
| AMG 531 | Ancillary Agent | No | |
| ATRA-IV | Differentiation inducing agent | Lymphoma, Acute promyelocytic leukemia | Yes |
| Abecma | Biologic therapy (BRM, immunotherapy) | Yes | |
| Abemaciclib | Chemotherapy | Breast | Yes |
| Abiraterone acetate | Hormones and hormonal mechanisms | Prostate | Yes |
| Abraxane | Chemotherapy | Metastatic breast cancer, NSCLC, Non small cell lung cancer, cervix, melanoma, pancreas | Yes |
| Acalabrutinib | Chemotherapy | Yes | |
| Accutane | Differentiation inducing agent | Prostate cancer | No |
| Acetaminophen | Ancillary Agent | No | |
| Acetazolamide | Ancillary Agent | No | |
| Acetylcysteine | Ancillary Agent | AIDS, Opportunistic infection | No |
| Acitretin | Differentiation inducing agent | No | |
| Acyclovir | Ancillary Agent | No | |
| Acyclovir Sodium | AIDS drug | No | |
| Ad5CMV-p53 (adenovirus p53) | Biologic therapy (BRM, immunotherapy) | Glioma, Head & neck, lung cancer | No |
| Ado-trastuzumab emtansine | Biologic therapy (BRM, immunotherapy) | Metastatic HER-2 breast cancer | Yes |
| Adrenocorticotropic hormone | Hormones and hormonal mechanisms | See Remarks | |
| Adstiladrin | Biologic therapy (BRM, immunotherapy) | bladder | Yes |
| Afinitor | Chemotherapy | breast, Lung, other cancer | Yes |
| Akeega | Chemotherapy | Prostate | See Remarks |
| Albendazole | AIDS drug | No | |
| Albuterol Sulfate | Ancillary Agent | No | |
| Alectinib | Chemotherapy | Lung, Lymphoma | Yes |
| Alemtuzumab | Biologic therapy (BRM, immunotherapy) | Leukemia, lymphoma | Yes |
| Alendronate Sodium | Ancillary Agent | No | |
| Alitretinoin | Differentiation inducing agent | Breast, Kaposi sarcoma, leukemia, sarcoma, skin cancer | No |
| Allopurinol | Ancillary Agent | No | |
| Allosteric ErbB Inhibitor BDTX-189 | Chemotherapy | Yes | |
| Alpharadin | Radiation | Bone metastases | Yes |
| Altretamine | Chemotherapy | Ovarian cancer | Yes |
| Amifostine | Ancillary Agent | Breast, leukemia, lymphoma, NSCLC, prostate, skin cancer | No |
| Aminocamptothecin | Chemotherapy | Leukemia, breast, lung cancer, lymphoma | Yes |
| Aminoglutethimide | Hormones and hormonal mechanisms | Yes | |
| Aminopterin | Chemotherapy | Leukemia | Yes |
| Aminosyn | Ancillary Agent | No | |
| Amtagvil | Biologic therapy (BRM, immunotherapy) | Yes | |
| Anagrelide HCl | Differentiation inducing agent | Essential thrombocythemia | Yes |
| Anastrozole | Hormones and hormonal mechanisms | Breast cancer | Yes |
| Ancitabine Hydrochloride | Chemotherapy | Yes | |
| Anktiva | Biologic therapy (BRM, immunotherapy) | Bladder | Yes |
| Antithymocyte Globulin | Biologic therapy (BRM, immunotherapy) | No | |
| Apaziquone | Ancillary Agent, Chemotherapy | Bladder cancer | See Remarks |
| Aprepitant | Ancillary Agent | No | |
| Asparaginase | Chemotherapy | Acute lymphoblastic leukemia (ALL) | Yes |
| Asparaginase (Erwinia carotovora) | Chemotherapy | Yes | |
| Asparaginase-PEG | Chemotherapy | Yes | |
| Asparaginase-PEG (K-H) | Chemotherapy | Yes | |
| Asparlas | Chemotherapy | Yes | |
| Aspirin | Other therapy | Essential Thrombocythemia | Yes |
| Atevirdine Mesylate | AIDS drug | No | |
| Atezolizumab | Biologic therapy (BRM, immunotherapy) | Bladder, Lung, Liver, Breast, Soft tissue | Yes |
| Atovaquone | AIDS drug | No | |
| Atripla | AIDS drug | No | |
| Aucatzyl | Biologic therapy (BRM, immunotherapy) | Yes | |
| Aut Tum Vac/BCG/IL-2 | Biologic therapy (BRM, immunotherapy) | Yes | |
| Aut Tum Vac/IL-2/BCG | Biologic therapy (BRM, immunotherapy) | Yes | |
| Aut Tum Vac/IL-2/BCG, Tice BCG Vaccine, frozen | Biologic therapy (BRM, immunotherapy) | Yes | |
| Autologous Tumor Cell (BCG + IL-2 (Cetus), | Biologic therapy (BRM, immunotherapy) | Yes | |
| Autologous Tumor Cell (BCG) + IL-2 (Bionetics), | Biologic therapy (BRM, immunotherapy) | Yes | |
| Autologous Tumor Cell Vaccine + BCG (Bionetics) | Biologic therapy (BRM, immunotherapy) | Yes | |
| Autologous Tumor Cell Vaccine + IL-2 (Cetus) | Biologic therapy (BRM, immunotherapy) | Yes | |
| Avapritinib | Chemotherapy | Yes | |
| Avelumab | Biologic therapy (BRM, immunotherapy) | Skin, Bladder | Yes |
| Axitinib | Chemotherapy | Colorectal, kidney, melanoma, pancreas, thyroid | Yes |
| Azacitidine | Chemotherapy | Leukemia | Yes |
| Azathioprine | Ancillary Agent | No | |
| Azidothymidine | Chemotherapy | Yes | |
| BCG | Biologic therapy (BRM, immunotherapy) | Yes | |
| BCG - Connaught | Biologic therapy (BRM, immunotherapy) | Yes | |
| BCG - TheraCys | Biologic therapy (BRM, immunotherapy) | Yes | |
| BCG - Tice | Biologic therapy (BRM, immunotherapy) | Yes | |
| BCG Vaccine | Biologic therapy (BRM, immunotherapy) | Yes | |
| BCG Vaccine - Connaught | Biologic therapy (BRM, immunotherapy) | Yes | |
| Baker's antifol | Chemotherapy | Yes | |
| Basiliximab | Ancillary Agent | No | |
| Bcl-2/Bcl-x1 Inhibitor | Chemotherapy | Other cancer | Yes |
| Beclomethasone Dipropionate | Ancillary Agent, Hormones and hormonal mechanisms | No | |
| Bectumomab | Biologic therapy (BRM, immunotherapy) | Yes | |
| Belantamab mafodotin-blmf | Biologic therapy (BRM, immunotherapy) | Yes | |
| Belinostat | Chemotherapy | CLL, Multiple myeloma, NHL, advanced malignancies, others, peripheral T-cell lymphoma (PTCL) | Yes |
| Belotecan | Chemotherapy | Yes | |
| Belzutifan | Chemotherapy | Kidney, Brain, Pancreas, Adrenal gland | Yes |
| Bemarituzumab | Biologic therapy (BRM, immunotherapy) | Stomach, Esophagus | Yes |
| Bemcentinib | Chemotherapy | See Remarks | |
| Bendamustine | Chemotherapy | breast, CLL, HL, Multiple myeloma, NHL | Yes |
| Benzestrol | Hormones and hormonal mechanisms | Yes | |
| Benznidazole | Ancillary Agent | No | |
| Benzquinamide Hydrochloride | Ancillary Agent | No | |
| Berubicin | Chemotherapy | Brain | Yes |
| Besponsa | Biologic therapy (BRM, immunotherapy) | Yes | |
| Besremi | Biologic therapy (BRM, immunotherapy) | Yes | |
| Beta Carotene | Ancillary Agent | No | |
| Betamethasone | Hormones and hormonal mechanisms | See Remarks | |
| Betamethasone Acetate | Hormones and hormonal mechanisms | See Remarks | |
| Betamethasone Benzoate | Hormones and hormonal mechanisms | See Remarks |
Home